Insider · CIK 0001431437

Clarus Ventures II, LLC

CIK 0001431437 Name as filed on the most recent filing

Filed as Clarus Ventures II, LLC (23)

45 transaction lines · from 23 filings · filed 2008-09-09 to 2018-09-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-09-17 S, Open-market sale NanoString Technologies IncNSTG 1,372,310, disposed Open Form 4 filing 0001401708-18-000122
2016-02-09 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 36,881, disposed Open Form 4 filing 0001012975-16-000991
2016-02-08 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 19,593, disposed Open Form 4 filing 0001012975-16-000991
2016-02-05 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 166,576, disposed Open Form 4 filing 0001012975-16-000980
2016-02-04 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 70,004, disposed Open Form 4 filing 0001012975-16-000980
2016-02-03 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 12,387, disposed Open Form 4 filing 0001012975-16-000980
2016-02-02 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 29,972, disposed Open Form 4 filing 0001012975-16-000957
2016-02-01 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 28,000, disposed Open Form 4 filing 0001012975-16-000957
2016-01-29 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 13,735, disposed Open Form 4 filing 0001012975-16-000957
2016-01-28 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 8,455, disposed Open Form 4 filing 0001012975-16-000938
2016-01-27 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 56,696, disposed Open Form 4 filing 0001012975-16-000938
2016-01-26 S, Open-market sale Tetralogic Pharmaceuticals CorpTLOG 20,828, disposed Open Form 4 filing 0001012975-16-000938
2015-06-30 P, Open-market purchase Catabasis Pharmaceuticals IncCATB 4,520,340, acquired Open Form 4 filing 0001104659-15-049019
2015-01-08 S, Open-market sale Aerie Pharmaceuticals IncAERI 5,444,250, disposed Open Form 4 filing 0001012975-15-000017
2015-01-05 S, Open-market sale Aerie Pharmaceuticals IncAERI 2 lines 728,913, disposed Open Form 4 filing 0001012975-15-000003
2014-12-29 S, Open-market sale Aerie Pharmaceuticals IncAERI 186,606, disposed Open Form 4 filing 0001012975-14-000835
2014-12-26 S, Open-market sale Aerie Pharmaceuticals IncAERI 2,239,026, disposed Open Form 4 filing 0001012975-14-000835
2014-12-23 S, Open-market sale Aerie Pharmaceuticals IncAERI 7,890, disposed Open Form 4 filing 0001012975-14-000826
2014-12-22 S, Open-market sale Aerie Pharmaceuticals IncAERI 1,501,029, disposed Open Form 4 filing 0001012975-14-000826
2014-06-11 S, Open-market sale Ophthotech Corp.OPHT 2 lines 1,323,234, disposed Open Form 4 filing 0001012975-14-000396
2014-06-10 S, Open-market sale Ophthotech Corp.OPHT 3 lines 5,266,977, disposed Open Form 4 filing 0001012975-14-000396
2014-06-09 S, Open-market sale Ophthotech Corp.OPHT 2 lines 3,023,963, disposed Open Form 4 filing 0001012975-14-000396
2013-12-17 P, Open-market purchase Tetralogic Pharmaceuticals CorpTLOG 9,975,441, acquired Open Form 4 filing 0001192482-13-000240
2013-10-25 P, Open-market purchase Aerie Pharmaceuticals IncAERI 3,210,000, acquired Open Form 4 filing 0001012975-15-000076
2013-10-25 P, Open-market purchase Aerie Pharmaceuticals IncAERI 3,210,000, acquired Open Form 4 filing 0001012975-13-000497
2013-07-01 P, Open-market purchase NanoString Technologies IncNSTG 7,500,000, acquired Open Form 4 filing 0001209191-13-034478
2012-05-31 S, Open-market sale Achillion Pharmaceuticals IncACHN 2 lines 9,868,215, disposed Open Form 4 filing 0001012975-12-000163
2010-08-20 P, Open-market purchase Achillion Pharmaceuticals IncACHN 12,140,000, acquired Open Form 4 filing 0001012975-10-000292
2010-01-11 S, Open-market sale Achillion Pharmaceuticals IncACHN 881,370, disposed Open Form 4 filing 0001012975-10-000008
2010-01-07 S, Open-market sale Achillion Pharmaceuticals IncACHN 12,600, disposed Open Form 4 filing 0001012975-10-000002
2010-01-06 S, Open-market sale Achillion Pharmaceuticals IncACHN 173,033, disposed Open Form 4 filing 0001012975-10-000002
2009-12-24 S, Open-market sale Achillion Pharmaceuticals IncACHN 12,695, disposed Open Form 4 filing 0001012975-09-000362
2009-12-23 S, Open-market sale Achillion Pharmaceuticals IncACHN 981,428, disposed Open Form 4 filing 0001012975-09-000360
2009-12-21 S, Open-market sale Achillion Pharmaceuticals IncACHN 67,664, disposed Open Form 4 filing 0001012975-09-000360
2009-12-18 S, Open-market sale Achillion Pharmaceuticals IncACHN 34,650, disposed Open Form 4 filing 0001012975-09-000358
2009-12-17 S, Open-market sale Achillion Pharmaceuticals IncACHN 453,166, disposed Open Form 4 filing 0001012975-09-000358
2009-12-16 S, Open-market sale Achillion Pharmaceuticals IncACHN 242,507, disposed Open Form 4 filing 0001012975-09-000358
2008-09-08 P, Open-market purchase Achillion Pharmaceuticals IncACHN 3,791, acquired Open Form 4 filing 0001012975-08-000149
2008-09-05 P, Open-market purchase Achillion Pharmaceuticals IncACHN 6,693, acquired Open Form 4 filing 0001012975-08-000149

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Clarus Ventures II, LLC, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001431437

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.